A new peer-reviewed study published in JAMA Pediatrics has found that neonatal mortality-the death of an infant within the first 28 days of life- fell by 50% following the launch of Rx Kids, while early neonatal mortality-the death of an infant within the first 7 days of life-fell by 74%.